Bioporto abandons Merlin Diagnostica GmbH takeover.

(From Chemical Business NewsBase - Net Posten)

Bioporto's board has decided not to go ahead with the takeover of Merlin Diagnostics because it has not been demonstrated that outstanding matters pertaining to due diligence can be resolved. In addition, an assessment of the circumstances within Merlin Diagnostica suggests that it is highly uncertain whether the required optimization of newly developed Micronaut products can be carried out quickly enough for the share of the domestic market (which accounts for the bulk of sales) to be maintained without further customer loss or at least with a reduced customer loss, regardless of whether Bioporto chooses to …